We are live on ! Find out more
STAA icon

STAAR Surgical

196 hedge funds and large institutions have $1.36B invested in STAAR Surgical in 2025 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 45 increasing their positions, 64 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 65 | Existing positions closed: 39

50% more capital invested

Capital invested by funds: $904M → $1.36B (+$455M)

15% more funds holding

Funds holding: 170196 (+26)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

6.23% less ownership

Funds ownership: 108.74%102.52% (-6.2%)

30% less repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 64

43% less call options, than puts

Call options by funds: $10.2M | Put options by funds: $17.7M

Holders
196
Holders Change
+26
Holders Change %
+15.29%
% of All Funds
2.57%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
65
Increased
45
Reduced
64
Closed
39
Calls
$10.2M
Puts
$17.7M
Net Calls
-$7.57M
Net Calls Change
-$8.85M

STAA Hedge Fund Activity: Q3 2025 in Review

196 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in STAAR Surgical (STAA) for Q3 2025, worth a combined $1.36B — up 50% from $904M a quarter earlier.

Buyers outnumbered sellers: 65 funds opened new STAA positions and 39 closed out — a net gain of 26 holders — while 45 added to existing stakes and 64 trimmed.

The largest buyer was Balyasny Asset Management, opening a new position worth an estimated $43.2M. The largest seller was Soleus Capital Management, cutting an estimated $59.2M.

  • 196 institutional investors held STAAR Surgical (STAA) as of Q3 2025, up from 170 in Q2 2025.
  • Funds reported $1.36B of STAAR Surgical stock for Q3 2025, up 50% quarter-over-quarter.
  • 65 funds opened new STAAR Surgical positions in Q3 2025 and 39 closed out, a net change of +26 holders.
  • The largest STAAR Surgical buyer in Q3 2025 was Balyasny Asset Management, an estimated $43.2M added.
  • The largest STAAR Surgical seller in Q3 2025 was Soleus Capital Management, an estimated $59.2M sold.

Based on aggregated 13F filings for Q3 2025.